SCTX

12.1608.02%
JB

Joshua Bleharski

Chief Financial Officer

Dr. Joshua Bleharski, Ph.D., M.B.A., is Chief Financial Officer of IDEAYA Biosciences, Inc. from May 2025. Dr. Bleharski joined the IDEAYA Biosciences, Inc. on May 1, 2025. Prior to IDEAYA. Dr. Bleharski served as a Managing Director and Global Co-Head of Biopharma with J.P. Morgan's Healthcare Investment Banking group. Dr. Bleharski is Lead Independent Director of Scribe Therapeutics Inc. from July 23, 2026. Prior to that, Dr. Bleharski served in a variety of roles at J.P Morgan’s Healthcare Investment Banking group from July 2008 to April 2025, most recently as a Managing Director and Global Co-Head of Biopharma. He worked as a Senior Staff Scientist at a private biotechnology company in San Diego and was a post-doctoral fellow at the La Jolla Institute for Allergy and Immunology (LIAI) and the UCLA School of Medicine. Dr. Bleharski has B.S. in Biology from Duke University. Dr. Bleharski has Ph.D. in Immunology and Microbiology from University of California, Los Angeles. Dr. Bleharski has M.B.A. from University of California, Berkeley Haas School of Business.

Positions